Atrial natriuretic factor does not affect norepinephrine catabolism in rat hypothalamus and adrenal medulla

Neuroscience Letters

Volumn 253, Issue 3, 1998, Pages 151-154

  Vatta, Marcelo S ^a   Rubio, Modesto ^b   Bianciotti, Liliana G ^a   Fernandez, Belisario E ^a  

^a Ciudad Autonoma de Buenos Aires   (Argentina)

^b Instituto de Investigaciones Farmacologicas   (Argentina)

Author keywords

Adrenal medulla; Atrial natriuretic factor; Catechol O methyl transferase activity; Hypothalamus; Monoamine oxidase activity; Norepinephrine catabolism; Norepinephrine deaminates metabolites

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ATRIAL NATRIURETIC FACTOR; CATECHOL METHYLTRANSFERASE; NORADRENALIN;

ADRENAL MEDULLA; ANIMAL TISSUE; ARTICLE; CATABOLISM; CATECHOLAMINE METABOLISM; ENZYME ACTIVITY; HORMONE RELEASE; HYPOTHALAMUS; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

ADRENAL MEDULLA; ANIMALS; ATRIAL NATRIURETIC FACTOR; CATECHOL O-METHYLTRANSFERASE; ENZYME ACTIVATION; HYPOTHALAMUS; MALE; MANDELIC ACIDS; METHOXYHYDROXYPHENYLGLYCOL; MONOAMINE OXIDASE; NOREPINEPHRINE; NORMETANEPHRINE; RATS; RATS, WISTAR;

EID: 0032480220     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00623-5     Document Type: Article

References (25)

1. Berkowitz B.A., Tarver J.J., Spector S. Control of norepinephrine synthesis in blood vessels and the effects of monoamine oxidase inhibition. J. Pharmacol. Exp. Ther. 190:1974;21-29.
2. Berry M.D., Jourio A.V., Paterson I.A. The functional role of monoamine oxidases A and B in the mammalian central nervous system. Prog. Neurobiol. 42:1994;375-391.
3. Brenner B.M., Ballermann B.J., Gunning M.E., Zeidel M.L. Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70:1990;665-699.
4. Clarke D.E., Sampath S.S. Studies on the functional role of intraneuronal monoamine oxidase. J. Pharmacol. Exp. Ther. 187:1973;539-549.
5. de Bold A.J., Borenstein H.B., Veress A.T., Sonnenberg G.H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rat. Life Sci. 28:1981;89-94.
6. de Bold A.J., Bruneau B.G., Kuroski de Bold M.L. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc. Res. 31:1996;7-18.
7. Fernandez B.E., Dominguez A.E. Effects of angiotensin II and bilateral nephrectomy on norepinephrine catabolism in central nervous system. Arch. Int. Physiol. Biochim. 98:1990;307-313.
8. Fernandez B.E., Vatta M.S., Bianciotti L.G., Martinez-Seeber A. Atrial natriuretic peptide: effects on uptake and intracellular distribution of norepinephrine in hypothalamus. Pharmacol. (Life Sci. Adv.). 9:1990;525-533.
9. Fernandez B.E., Leder M., Fernandez G., Bianciotti L.G., Vatta M.S. Atrial natriuretic factor modifies the biosynthesis and turn over of norepinephrine in the rat adrenal medulla. Biochem. Biophys. Res. Commun. 238:1997;343-346.
10. 3H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem. Pharmacol. 22:1973;1147-1160.
11. Jarrott B. Occurrence and properties of catechol-O-methyl transferase in adrenergic neurons. J. Neurochem. 18:1971;17-27.
12. Kopin I.J. Monoamine oxidase and catecholamine metabolism. J. Neural. Transm. 41:1994;57-67.
13. Luque J.M., Kwan S.-W., Abell C.W., Da Prada M., Richards J.G. Cellular expression of mRNAs encoding monoamine oxidase A and B in the rat central nervous system. J. Comp. Neurol. 363:1995;665-680.
14. Majewski H., Hedler L., Steppeler A., Starke K. Metabolism of endogenous and exogenous noradrenaline in the rabbit perfused heart. Naunyn Schmiedeberg's Arch. Pharmacol. 319:1982;125-129.
15. Manger, W.M. and Gifford, R.W., Jr., Pheochromocytoma: a clinical overview. In J.H. Laragh and B.M. Brenner (Eds.), Hypertension: Pathophysiology, Diagnosis and Management, 2nd edn., Raven Press, New York, 1995, pp. 713-740.
16. Mc Caman R.E., Mc Caman M.W., Hunt J.W., Smith S.M. Microdetermination of monoamine oxidase and 5-hydroxytryptophan decarboxylase in nervous tissue. J. Neurochem. 12:1965;15-23.
17. Nakamaru M., Ogihara T., Saito H., Rakugi H., Hashizume K., Yamatodani A., Wada H., Kumahara Y. Effect of atrial natriuretic peptide on catecholamine release from human pheochromocytoma. Acta Endocrinol. 120:1989;107-112.
18. Naruse M., Takeyama Y., Tanabe A., Hiroshige J., Naruse K., Yoshimoto T., Tanaka M., Kalagiri T., Demura H. Atrial and brain natriuretic peptide in cardiovascular diseases. Hypertension. 23:1994;1231-1234.
19. Oparil, S., Chen, Y.-F., Berecek, K.H., Calhoun, D.A. and Wyss, J.M., The role of the central nervous system in hypertension. In J.H. Laragh and B.M. Brenner (Eds.), Hypertension: Pathophysiology, Diagnosis and Management, 2nd edn., Raven Press, New York, 1995, pp. 713-740.
20. Reinhard J.F., Roth R.H. Noradrenergic modulation of serotonine synthesis and metabolism. I. Inhibition by clonidine in vivo. J. Pharmacol. Exp. Ther. 221:1982;541-546.
21. Robertson, D., Disorders of autonomic cardiovascular regulation: baroreflex failure, autonomic failure, and orthostatic intolerance syndromes. In J.H. Laragh and B.M. Brenner (Eds.), Hypertension: Pathophysiology, Diagnosis and Management, 2nd edn., Raven Press, New York, 1995. pp. 941-959.
22. Starke K., Hedler L., Steppeler A. Metabolism of endogenous and exogenous noradrenaline in guinea pig atria. Naunyn Schmiedeberg's Arch. Pharmacol. 317:1981;193-198.
23. Skofitsch G., Jacobowitz D.M. Atrial natriuretic peptide in central nervous system of the rat. Cell. Mol. Neurobiol. 8:1988;339-391.
24. Vatta M.S., Bianciotti L.G., Fernandez B.E. Influence of atrial natriuretic factor on uptake, intracellular distribution and release of norepinephrine in rat adrenal medulla. Can. J. Physiol. Pharmacol. 71:1993;195-200.
25. Vatta M.S., Papouchado M.L., Locatelli A.S., Bianciotti L.G., Fernandez B.E. Effects of atrial natriuretic factor on norepinephrine release in the rat hypothalamus. Regul. Pept. 41:1992;171-181.